NEW YORK CITY, NEW YORK, USA, January 31, 2024 /EINPresswire / -- Creative Bioarray, a distinguished pioneer in the biotechnology field, has developed avant-garde ADCC, CDC, and ADCP assays catered ...
MT201 is a fully human monoclonal IgG1 antibody with moderate affinity for epithelial cell adhesion molecule (Ep-CAM) being clinically developed for the treatment of carcinomas. Like many other ...
A recent Keystone meeting highlighted the progress in developing antibody-based therapeutics for cancer. You have full access to this article via your institution ...
NEW YORK CITY, NEW YORK, USA, January 31, 2024 /EINPresswire.com/ -- Creative Bioarray, a distinguished pioneer in the biotechnology field, has developed avant-garde ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback